Ocular Manifestations in Rheumatic Diseases

NCT03753893 | Completed

• 1 other identifier: MTJP001
• Study Type: observational
• Target: 5,000
• Locations: 0 countries
• Sites: N/A

Brief Summary

This is a search strategy for determining the prevalence of ocular complications in inflammatory rheumatic diseases for the purposes of a meta analysis.

Conditions

Uveitis; Conjunctivitis; Keratoconjunctivitis Sicca; Xerophthalmia; Eye Hemorrhage; Optic Neuritis; Papilledema; Orbital Diseases; Retinal Vein Occlusion; Retinal Artery Occlusion; Macular Edema; Retinitis; Chorioretinitis; Iridocyclitis; Scleritis; Choroid Hemorrhage; Blindness; Amaurosis Fugax

Outcome Measures

Primary Outcomes (1)

• Prevalence of ocular manifestations of inflammatory rheumatic diseases

  Prevalence of ocular manifestations of inflammatory rheumatic diseases

  data is collected once per year up to 2020

Interventions

No intervention used OTHER

no intervention used

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients with ocular involvement in inflammatory rheumatic disease

You may qualify if:

• Studies were included if they provided numerical data of the prevalence or incidence of ocular manifestations in inflammatory rheumatic disease

You may not qualify if:

• review articles,
• case reports where all patients experienced the same ocular comorbidity
• if different comorbidities were not grouped independently
• if the study reported on fewer than 20 patients

Sponsors & Collaborators

• London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's: lead

MeSH Terms

Conditions

Uveitis; Conjunctivitis; Keratoconjunctivitis Sicca; Xerophthalmia; Eye Hemorrhage; Optic Neuritis; Papilledema; Orbital Diseases; Retinal Vein Occlusion; Retinal Artery Occlusion; Macular Edema; Retinitis; Chorioretinitis; Iridocyclitis; Scleritis; Choroid Hemorrhage; Blindness; Amaurosis Fugax

Condition Hierarchy (Ancestors)

Uveal Diseases; Eye Diseases; Conjunctival Diseases; Keratoconjunctivitis; Keratitis; Corneal Diseases; Dry Eye Syndromes; Lacrimal Apparatus Diseases; Hemorrhage; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Eye Manifestations; Signs and Symptoms; Optic Nerve Diseases; Cranial Nerve Diseases; Nervous System Diseases; Retinal Diseases; Venous Thrombosis; Thrombosis; Embolism and Thrombosis; Vascular Diseases; Cardiovascular Diseases; Arterial Occlusive Diseases; Macular Degeneration; Retinal Degeneration; Choroiditis; Choroid Diseases; Uveitis, Posterior; Panuveitis; Iris Diseases; Uveitis, Anterior; Scleral Diseases; Vision Disorders; Sensation Disorders; Neurologic Manifestations

Study Officials

• Janet Pope, MD

  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: ECOLOGIC OR COMMUNITY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor of Medicine

Study Record Dates

• First Submitted: October 31, 2018
• First Posted: November 27, 2018
• Study Start: May 1, 2013
• Primary Completion: April 1, 2021
• Study Completion: November 1, 2021
• Last Updated: April 12, 2022

Record last verified: 2022-04

Data Sharing

• IPD Sharing: Will not share